With the change of social model and the improvement of living conditions, the base of obesity patients is getting larger and larger, and the market of weight loss products is getting larger and larger, then, what are the weight loss drugs currently available? Weight loss drugs that has been approved Weight loss drugs that have been approved include but are not …
CagriSema, a combination of cagrilintide and semaglutide, is a promising treatment for obesity, especially in patients with type 2 diabetes and cardiovascular disease. The new drug combines two active ingredients :cagrilintide(a lake enzyme analogue) and semaglutide(a GLP-1 receptor agonist), both of which play important roles in appetite regulation and glucose control. CagriSema Action mechanism Semaglutide is best known for its …